Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 3
2007 1
2008 1
2010 1
2011 1
2012 2
2013 1
2014 3
2015 3
2016 11
2017 3
2018 4
2019 4
2020 3
2021 4
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial.
Bosheva M, Tokodi I, Krasnow A, Pedersen HK, Lukjancenko O, Eklund AC, Grathwohl D, Sprenger N, Berger B, Cercamondi CI; 5 HMO Study Investigator Consortium. Bosheva M, et al. Front Nutr. 2022 Jul 6;9:920362. doi: 10.3389/fnut.2022.920362. eCollection 2022. Front Nutr. 2022. PMID: 35873420 Free PMC article.
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
Wolf J, Kalocsai K, Fortuny C, Lazar S, Bosis S, Korczowski B, Petit A, Bradford D, Croos-Dabrera R, Incera E, Melis J, van Maanen R. Wolf J, et al. Among authors: korczowski b. Clin Infect Dis. 2020 Dec 17;71(10):2581-2588. doi: 10.1093/cid/ciz1149. Clin Infect Dis. 2020. PMID: 31773143 Free PMC article. Clinical Trial.
Identification of Iatrogenic Perforation in Pediatric Gastrointestinal Endoscopy.
Ledder O, Woynarowski M, Kamińska D, Łazowska-Przeorek I, Pieczarkowski S, Romano C, Lev-Tzion R, Holon M, Nita A, Rybak A, Jarocka-Cyrta E, Korczowski B, Czkwianianc E, Hojsak I, Szaflarska-Popławska A, Hauser B, Scheers I, Sharma S, Oliva S, Furlano R, Tzivinikos C, Liu QY, Giefer M, Mamula P, Grossman A, Kelsen J, Edelstein B, Antoine M, Thomson M, Homan M. Ledder O, et al. Among authors: korczowski b. J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):401-406. doi: 10.1097/MPG.0000000000003852. Epub 2023 Jun 5. J Pediatr Gastroenterol Nutr. 2023. PMID: 37276149
Wolfram Syndrome. Case report.
Tarała W, Drachal E, Mazur A, Korczowski B, Szadkowska A, Zmysłowska A, Młynarski W. Tarała W, et al. Among authors: korczowski b. Pediatr Endocrinol Diabetes Metab. 2016;22(1):39-42. doi: 10.18544/PEDM-22.01.0049. Pediatr Endocrinol Diabetes Metab. 2016. PMID: 28132072 Free article. English.
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group. Peyrin-Biroulet L, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798039 Free article. Clinical Trial.
Enhanced Rehabilitation Outcomes of Robotic-Assisted Gait Training with EksoNR Lower Extremity Exoskeleton in 19 Stroke Patients.
Wiśniowska-Szurlej A, Wołoszyn N, Brożonowicz J, Ciąpała G, Pietryka K, Grzegorczyk J, Leszczak J, Ćwirlej-Sozańska A, Sozański B, Korczowski B. Wiśniowska-Szurlej A, et al. Among authors: korczowski b. Med Sci Monit. 2023 Jul 15;29:e940511. doi: 10.12659/MSM.940511. Med Sci Monit. 2023. PMID: 37452491 Free PMC article.
54 results